# An Innovative Trial Assessing Donor Sex on Recipient Mortality

> **NCT03344887** · PHASE4 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 8850 (actual)

## Conditions studied

- Red Blood Cell Transfusion

## Interventions

- **OTHER:** RBC Transfusion from male donor
- **OTHER:** RBC Transfusion from female donor

## Key facts

- **NCT ID:** NCT03344887
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-04
- **Primary completion:** 2021-01-23
- **Final completion:** 2022-12-01
- **Target enrollment:** 8850 (ACTUAL)
- **Last updated:** 2022-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03344887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03344887, "An Innovative Trial Assessing Donor Sex on Recipient Mortality". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03344887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*